Evaluation of syncope: focus on diagnosis and treatment of neurally mediated syncope

References

• Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009): the task force for the diagnosis and management of syncope of the European Society of Cardiology (ESC). Eur Heart J. 2009;30:2631–2671.
   PubMed Web of Science ®Google Scholar
• Mosqueda-Garcia R, Furlan R, Tank J, et al. The elusive pathophysiology of neurally mediated syncope. Circulation. 2000;102:2898–2906.
   PubMed Web of Science ®Google Scholar
• Sheldon RS, Grubb BP, Olshansky B, et al. Heart Rhythm Society Expert Consensus Statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12:e41–e63.
   PubMed Web of Science ®Google Scholar
• Ganzeboom KS, Mairuhu G, Reitsma JB, et al. Lifetime cumulative incidence of syncope in the general population: a study of 549 dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol. 2006;17:1172–1176.
   PubMed Web of Science ®Google Scholar
• Sheldon RS, Sheldon AG, Connolly SJ, et al. Age of first faint in patients with vasovagal syncope. J Cardiovas Electrophysiol. 2006;17:49–54.
   PubMed Web of Science ®Google Scholar
• Moya A, Brignole M, Menozzi C, et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001;104:1261–1261.
   PubMed Web of Science ®Google Scholar
• Brignole M, Menozzi C, Bartoletti A, et al. A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J. 2006;27:76–82.
   PubMed Web of Science ®Google Scholar
• Blad H, Lamberts RJ, Van Dijk JG, et al. Tilt-induced vasovagal syncope and psychogenic pseudosyncope, overlying clinical entities. Neurology. 2015;85:2006–2010.
   PubMed Web of Science ®Google Scholar
• Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci. 2011;161:46–48.
   PubMed Web of Science ®Google Scholar
• Kaufmann H, Hainsworth R. Why do we faint? Muscle Nerve. 2001;24:981–983.
   PubMed Web of Science ®Google Scholar
• Fu Q, Levine BD. Pathophysiology of neurally mediated syncope: role of cardiac output and total peripheral resistance. Auton Neurosci. 2014;184:24–26.
   PubMed Web of Science ®Google Scholar
• Vaddadi G, Guo L, Esler M, et al. Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes. Circ Arrhythm Electrophysiol. 2011;4:711–718.
   PubMed Web of Science ®Google Scholar
• Onishi Y, Minoura Y, Chiba Y, et al. Daily dysfunction of autonomic regulation based on ambulatory blood pressure monitoring in patients with neurally mediated reflex syncope. Pacing Clin Electrophysiol. 2015;38:997–1004.
   PubMed Web of Science ®Google Scholar
• Bae MH, Kang JK, Kim NY, et al. Clinical characteristics of defecation and micturition syncope compared with common vasovagal syncope. Pacing Clin Electrophysiol. 2012;35:341–347.
   PubMed Web of Science ®Google Scholar
• Hak Tea S, Mansourati J, L’Heveder G, et al. New insights into the pathophysiology of carotid sinus syndrome. Circulation. 1996;93:1411–1416.
   PubMed Web of Science ®Google Scholar
• Tan MP, Kenny RAM, Chadwick TJ, et al. Carotid sinus hypersensitivity: disease state or clinical sign of ageing? Insights from a controlled study of autonomic function in symptomatic and asymptomatic subjects. Europace. 2010;12:1630–1636.
   PubMed Web of Science ®Google Scholar
• Jones PK, Gibbons CH. The role of autonomic testing in syncope. Auton Neurosci. 2014;184:40–45.
   PubMed Web of Science ®Google Scholar
• Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol. 2015;66:848–860.
   PubMed Web of Science ®Google Scholar
• Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, et al. Orthostatic hypotension in Parkinson disease: how much you fall or how low you go? Mov Disord. 2015;30:639–645.
   PubMed Web of Science ®Google Scholar
• Arbogast SD, Alshekhlee A, Hussain Z, et al. Hypotension unawareness in profound orthostatic hypotension. Am J Med. 2009;122:574–580.
   PubMed Web of Science ®Google Scholar
• Kaufmann H, Norcliffe-Kaufman L, Palma JA. Droxidopa in neurogenic orthostatic hypotension. Expert Rev Cardiovasc Ther. 2015;13:875–891.
   PubMed Web of Science ®Google Scholar
• Militianu A, Salacata A, Seibert K, et al. Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope. J Cardiovasc Electrophysiol. 1997;8:1087–1097.
   PubMed Web of Science ®Google Scholar
• D’Ascenzo F, Biondi-Zoccai G, Reed MJ, et al. Incidence, etiology and predictors of adverse outcomes in 43,315 patients presenting to the emergency department with syncope: an international meta-analysis. Int J Cardiol. 2013;167:57–62.
   PubMed Web of Science ®Google Scholar
• Solbiati M, Casazza G, Dipaola F, et al. Syncope recurrence and mortality: a systematic review. Europace. 2015;17:300–308.
   PubMed Web of Science ®Google Scholar
• Ruwald MH, Hansen ML, Lamberts M, et al. Prognosis among healthy individuals discharged with a primary diagnosis of syncope. J Am Coll Cardiol. 2013;61:325–332.
   PubMed Web of Science ®Google Scholar
• Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347:878–885.
   PubMed Web of Science ®Google Scholar
• Sumner GL, Rose MS, Koshman ML, et al. Recent history of vasovagal syncope in a young, referral-based population is a stronger predictor of recurrent syncope than lifetime syncope burden. J Cardiovasc Electrophysiol. 2010;21:1375–1380.
   PubMed Web of Science ®Google Scholar
• Rose MS, Koshman ML, Spreng S, et al. The relationship between health-related quality of life and frequency of spells in patients with syncope. J Clin Epidemiol. 2000;53:1209–1216.
   PubMed Web of Science ®Google Scholar
• Mitro P, Kirsch P, Valočik G, et al. Clinical history in the diagnosis of the cardiac syncope-the predictive scoring system. Pacing Clin Electrophysiol. 2011;34:1480–1485.
   PubMed Web of Science ®Google Scholar
• Sun BC, Costantino G, Barbic F, et al. Priorities for emergency department syncope research. Ann Emerg Med. 2014;64:649–655.
   PubMed Web of Science ®Google Scholar
• Saklani P, Krahn A, Klein G. Syncope. Circulation. 2013;127:1330–1339.
   PubMed Web of Science ®Google Scholar
• Sheldon R, Rose S, Ritchie D, et al. Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol. 2002;40:142–148.
   PubMed Web of Science ®Google Scholar
• Van Dijk N, Boer KR, Colman N, et al. High diagnostic yield and accuracy of history, physical examination, and ECG in patients with transient loss of consciousness in FAST: the Fainting Assessment Study. J Cardiovasc Electrophysiol. 2008;19:48–55.
   PubMed Web of Science ®Google Scholar
• Sheldon R. How to differentiate syncope from seizure. Card Electrophysiol Clin. 2013;5:423–431.
   Google Scholar
• Sheldon R, Rose S, Connolly S, et al. Diagnostic criteria for vasovagal syncope based on a quantitative history. Eur Heart J. 2006;27:344–350.
   PubMed Web of Science ®Google Scholar
• Romme JJCM, Van Dijk N, Boer KR, et al. Diagnosing vasovagal syncope based on quantitative history-taking: validation of the Calgary Syncope Symptom Score. Eur Heart J. 2009;30:2888–2896.
   PubMed Web of Science ®Google Scholar
• Sheldon R, Hersi A, Ritchie D, et al. Syncope and structural heart disease: historical criteria for vasovagal syncope and ventricular tachycardia. J Cardiovasc Electrophysiol. 2010;21:1358–1364.
   PubMed Web of Science ®Google Scholar
• Ventura R, Maas R, Rüppel R, et al. Psychiatric conditions in patients with recurrent unexplained syncope. Europace. 2001;3:311–316.
   PubMed Web of Science ®Google Scholar
• Humm AM, Mathias CJ. Abnormal cardiovascular responses to carotid sinus massage also occur in vasovagal syncope – implications for diagnosis and treatment. Eur J Neurol. 2010;17:1061–1067.
   PubMed Web of Science ®Google Scholar
• Richardson DA, Bexton R, Shaw FE, et al. Complications of carotid sinus massage - a prospective series of older patients. Age Ageing. 2000;29:413–417.
   PubMed Web of Science ®Google Scholar
• Morillo CA, Camacho ME, Wood MA, et al. Diagnostic utility of mechanical, pharmacological and orthostatic stimulation of the carotid sinus in patients with unexplained syncope. J Am Coll Cardiol. 1999;34:1587–1594.
   PubMed Web of Science ®Google Scholar
• Solari D, Maggi R, Oddone D, et al. Assessment of the vasodepressor reflex in carotid sinus syndrome. Circ Arrhythm Electrophysiol. 2014;7:505–519.
   PubMed Web of Science ®Google Scholar
• Brignole M, Vardas P, Hoffman E, et al. Indications for the use of diagnostic implantable and external ECG loop recorders. Europace. 2009;11:671–687.
   PubMed Web of Science ®Google Scholar
• Norcliffe-Kaufmann L, Kaufmann H. Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure? Clin Auton Res. 2014;24:189–192.
   PubMed Web of Science ®Google Scholar
• Locati ET, Moya A, Oliveira M, et al. External prolonged electrocardiogram monitoring in unexplained syncope and palpitations: results of the SYNARR-Flash study. Europace. 2015. Published online 2015 Oct 29. Available from: http://europace.oxfordjournals.org/lookup/doi/10.1093/europace/euv311.
   Google Scholar
• Fung E, Jarvelin M-R, Doshi RN, et al. Electrocardiographic patch devices and contemporary wireless cardiac monitoring. Front Physiol. 2015;6:1–10.
   PubMed Web of Science ®Google Scholar
• Barrett PM, Komatireddy R, Haaser S, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014;127:95.e11–95.e17.
   PubMed Web of Science ®Google Scholar
• Krahn AD, Klein GJ, Yee R, et al. Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. J Am Coll Cardiol. 2003;42:495–501.
   PubMed Web of Science ®Google Scholar
• Farwell DJ, Freemantle N, Sulke AN. Use of implantable loop recorders in the diagnosis and management of syncope. Eur Heart J. 2004;25:1257–1263.
   PubMed Web of Science ®Google Scholar
• Solano A, Menozzi C, Maggi R, et al. Incidence, diagnostic yield and safety of the implantable loop-recorder to detect the mechanism of syncope in patients with and without structural heart disease. Eur Heart J. 2004;25:1116–1119.
   PubMed Web of Science ®Google Scholar
• Brignole M, Sutton R, Menozzi C, et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J. 2005;27:1085–1092.
   Web of Science ®Google Scholar
• Brignole M, Menozzi C, Moya A, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation. 2012;125:2566–2571.
   PubMed Web of Science ®Google Scholar
• Krahn AD, Klein GJ, Yee R, et al. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 2001;104:46–51.
   PubMed Web of Science ®Google Scholar
• Podoleanu C, DaCosta A, Defaye P, et al. Early use of an implantable loop recorder in syncope evaluation: a randomized study in the context of the French healthcare system (FRESH study). Arch Cardiovasc Dis. 2014;107:546–552.
   PubMed Web of Science ®Google Scholar
• Kurbaan AS, Bowker TJ, Wijesekera N, et al. Age and hemodynamic responses to tilt testing in those with syncope of unknown origin. J Am Coll Cardio. 2003;41:1004–1007.
   PubMed Web of Science ®Google Scholar
• Forleo C, Guida P, Iacoviello M, et al. Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. Int J Cardiol. 2013;168:27–35.
   PubMed Web of Science ®Google Scholar
• El-Bedawi KM, Hainsworth R. Combined head-up tilt and lower body suction: a test of orthostatic tolerance. Clin Auton Res. 1994;4:41–47.
   PubMedGoogle Scholar
• Brignole M, Donateo P, Menozzi C. The diagnostic value of ATP testing in patients with unexplained syncope. Europace. 2003;5:425–428.
   PubMed Web of Science ®Google Scholar
• Fragakis N, Antoniadis AP, Saviano M, et al. The use of adenosine and adenosine triphosphate testing in the diagnosis, risk stratification and management of patients with syncope: current evidence and future perspectives. Int J Cardiol. 2015;183:267–273.
   PubMed Web of Science ®Google Scholar
• Deharo JC, Guieu R, Mechulan A, et al. Syncope without prodromes in patients with normal heart and normal electrocardiogram: a distinct entity. J Am Coll Cardiol. 2013;62:1075–1080.
   PubMed Web of Science ®Google Scholar
• Flammang D, Church TR, De Roy L, et al Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5ʹ-triphosphate testing. Circulation. 2012;125:31–36.
   PubMed Web of Science ®Google Scholar
• Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS Expert Consensus Statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10:1932–1963.
   PubMed Web of Science ®Google Scholar
• Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace. 2015;36:2793–2867.
   Google Scholar
• Russo AM, Stainback RF, Bailey SR, et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 Appropriate Use Criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy. J Am Coll Cardiol. 2013;61:1318–1368.
   PubMed Web of Science ®Google Scholar
• Pedersen CT, Kay GN, Kalman J, et al. EHRA/HRS/APHRS Expert Consensus on ventricular arrhythmias. Heart Rhythm. 2014;11:e166–e196.
   Web of Science ®Google Scholar
• Tracy CM, Epstein AE, Darbar D, et al. ACCF/AHA/HRS Focused Update incorporated into the ACCF/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol. 2013;61:e6–e75.
   Web of Science ®Google Scholar
• Romme JJ, Reitsma JB, Black CN, et al. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope. Cochrane Database Syst Rev. 2011;(10):CD004194.
   Google Scholar
• Aydin MA, Mortensen K, Salukhe TV, et al. A standardized education protocol significantly reduces traumatic injuries and syncope recurrence: an observational study in 316 patients with vasovagal syncope. Europace. 2012;14:410–415.
   PubMed Web of Science ®Google Scholar
• Krediet CP, Van Dijk N, Linzer M, et al. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation. 2002;106:1684–1689.
   PubMed Web of Science ®Google Scholar
• Brignole M, Croci F, Menozzi C, et al. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol. 2002;40:2053–2059.
   PubMed Web of Science ®Google Scholar
• Van Dijk N, Quartieri F, Blanc -J-J, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol. 2006;48:1652–1657.
   PubMed Web of Science ®Google Scholar
• Kuriachan V, Sheldon RS, Platonov M. Evidence-based treatment for vasovagal syncope. Heart Rhythm. 2008;5:1609–1614.
   PubMed Web of Science ®Google Scholar
• Sheldon R, Connolly S, Rose S, et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation. 2006;113:1164–1170.
   PubMed Web of Science ®Google Scholar
• Sheldon R, Rose S, Flanagan P, et al. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol. 1996;78:536–539.
   PubMed Web of Science ®Google Scholar
• Sheldon RS, Morillo CA, Klingenheben T, et al. Age-dependent effect of β-blockers in preventing vasovagal syncope. Circ Arrhythm Electrophysiol. 2012;5:920–926.
   PubMed Web of Science ®Google Scholar
• Raj SR, Rose S, Ritchie D, et al. The Second Prevention of Syncope Trial (POST II)- a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design. Am Heart J. 2006;151:11–17.
   Web of Science ®Google Scholar
• Salim MA, Di Sessa TG. Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial. J Am Coll Cardiol. 2005;45:484–488.
   PubMed Web of Science ®Google Scholar
• Wright RA, Kaufmann HC, Perera R, et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology. 1998;51:120–124.
   PubMed Web of Science ®Google Scholar
• Qingyou Z, Junbao D, Chaoshu T. The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope. J Pediatr. 2006;149:777–780.
   PubMed Web of Science ®Google Scholar
• Kaufmann H, Saadia D, Voustianiouk A. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol. 2002;52:342–345.
   PubMed Web of Science ®Google Scholar
• Romme JJCM, Van Dijk N, Go-Schön IK, et al. Effectiveness of Midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial). Europace. 2011;13:1639–1647.
   PubMed Web of Science ®Google Scholar
• Raj SR, Faris P, McRae M, et al. Rationale for the prevention of syncope trial IV: assessment of midodrine. Clin Auton Res. 2012;22:275–280.
   PubMed Web of Science ®Google Scholar
• Di Girolamo E, Di Iorio C, Sabatini P, et al. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1999;33:1227–1230.
   PubMed Web of Science ®Google Scholar
• Grubb BP, Samoil D, Kosinski D, et al. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol. 1994;24:490–494.
   PubMed Web of Science ®Google Scholar
• Takata TS, Wasmund SL, Smith ML, et al. Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation. 2002;106:1500–1504.
   PubMed Web of Science ®Google Scholar
• Theodorakis GN, Leftheriotis D, Livanis EG, et al. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study. Europace. 2006;8:193–198.
   PubMed Web of Science ®Google Scholar
• Ahmed N, Frontera A, Carpenter A, et al. Clinical predictors of pacemaker implantation in patients with syncope receiving implantable loop recorder with or without ECG conduction abnormalities. Pacing Clin Electrophysiol. 2015;38:934–941.
   PubMed Web of Science ®Google Scholar
• Palmisano P, Accogli M, Zaccaria M, et al. Predictive factors for pacemaker implantation in patients receiving an implantable loop recorder for syncope remained unexplained after an extensive cardiac and neurological workup. Int J Cardiol. 2013;168:1–8.
   PubMed Web of Science ®Google Scholar
• Kenny RA, for the SAFE PACE 2 study group. SAFE PACE 2: syncope and falls in the elderly-pacing and carotid sinus evaluation: a randomized controlled trial of cardiac pacing in older patients with falls and carotid sinus hypersensitivity. Europace. 1999;1:69–72.
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Sheldon R, Roberts RS, et al. The North American Vasovagal Pacemaker Study (VPS): A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol. 1999;33:16–20.
   PubMed Web of Science ®Google Scholar
• Sutton R, Brignole M, Menozzi C, et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope - Pacemaker versus no therapy: A multicenter randomized study. Circulation. 2000;102:294–299.
   PubMed Web of Science ®Google Scholar
• Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation. 2001;104:52–57.
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. Jama. 2003;289:2224–2229.
   PubMed Web of Science ®Google Scholar
• Sud S, Massel D, Klein GJ, et al. The expectation effect and cardiac pacing for refractory vasovagal syncope. Am J Med. 2007;120:54–62.
   PubMed Web of Science ®Google Scholar
• Raviele A, Giada F, Menozzi C, et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J. 2004;25:1741–1748.
   PubMed Web of Science ®Google Scholar
• Brignole M, Donateo P, Tomaino M, et al. The benefit of pacemaker therapy in patients with presumed neurally-mediated syncope and documented asystole is greater when tilt test is negative. An analysis from the Third International Study on Syncope of Uncertain Etiology (ISSUE-3). Circ Arrhythm Electrophysiol. 2014;7:10–16.
   PubMed Web of Science ®Google Scholar
• Brignole M, Ammirati F, Arabia F, et al. Assessment of a standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncopes. Eur Heart J. 2015;36:1529–1535.
   PubMed Web of Science ®Google Scholar